| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.3B | $4.3B | $4.7B | $7.1B | $4.6B | $1.3B | $1.0B | $1.0B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.9B | $0.0B | $0.5B | $2.6B | $0.0B | $0.1B | $-0.1B | $-0.0B |
| Net Income | $0.7B | $0.1B | $0.3B | $2.0B | $-0.2B | $0.1B | $-0.5B | $0.0B |
| EPS (Basic) | $2.05 | $0.18 | $0.81 | $6.18 | $-0.61 | $0.26 | $-1.61 | $-0.39 |
| EPS (Diluted) | $2.03 | $0.18 | $0.78 | $5.78 | $-0.61 | $0.24 | $-1.61 | $-0.39 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.2B | $13.0B | $13.6B | $14.1B | $13.9B | $13.2B | $15.2B | $15.5B |
| Current Assets | $0.8B | $0.5B | $0.5B | $0.8B | $0.7B | $0.6B | $0.9B | $0.8B |
| Cash & Equivalents | — | — | — | — | — | — | — | $0.0B |
| Total Liabilities | $5.5B | $5.8B | $6.4B | $7.1B | $7.8B | $7.1B | $8.2B | $7.0B |
| Current Liabilities | $1.5B | $1.4B | $1.5B | $1.8B | $2.1B | $1.0B | $1.0B | $0.9B |
| Stockholders' Equity | $7.6B | $7.0B | $7.0B | $6.8B | $5.8B | $5.8B | $7.0B | $7.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.6B | $0.8B | $1.0B | $3.1B | $1.7B | $0.7B | $1.1B | $2.1B |
| Investing Cash Flow | $-1.1B | $-0.7B | $-1.1B | $-0.9B | $-0.7B | $-0.5B | $-1.0B | $-2.4B |
| Capital Expenditures | — | — | — | $0.9B | $0.7B | $0.9B | $1.4B | — |
| Financing Cash Flow | $-0.3B | $-0.1B | $0.1B | $-2.1B | $-0.9B | $-0.2B | $0.6B | $0.2B |